LUCY THERAPEUTICS, INC.

Profile

Company Names

LUCY THERAPEUTICS, INC.

Addresses

21 HICKORY DRIVE, SUITE 2B, WALTHAM, MA 02451

501 MASSACHUSETTS AVENUE, CAMBRIDGE, MA 02139

Phone Numbers

617-249-4812

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$28,617,503.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2023-12-15 
$10,552,797.00 
$10,552,797.00 
$0.00 
Equity 
2
2021-12-22 
$15,044,707.00 
$20,000,000.00 
$4,955,293.00 
Equity 
1
2019-06-28 
$3,019,999.00 
$4,509,472.00 
$1,489,473.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANN 
 
DEWITT 
DIRECTOR
IMMUNEXCITE, INC.   |  KYTOPEN CORP.   |  LUCY THERAPEUTICS, INC.   |  CAMBRIDGE CROPS, INC.   |  SYZYGY PLASMONICS INC.   |  E25BIO INC.   |  QUAISE, INC.   |  VAXESS TECHNOLOGIES, INC.   |  DROPLET BIOSCIENCES, INC.   |  BIOBOT ANALYTICS, INC.   |  QUAISE ENERGY, INC.   |  KANO THERAPEUTICS INC.   |  TERRESTRIAL BIO, INC.
KAROLY 
 
NIKOLICH 
DIRECTOR
EXCELIMMUNE, INC   |  CHASE PHARMACEUTICALS CORP   |  ALKAHEST, INC.   |  CHROMADERM, INC.   |  BIOMMUNE TECHNOLOGIES INC.   |  CHASE THERAPEUTICS CORP   |  LUCY THERAPEUTICS, INC.
ROBERT 
MICHAEL 
POOLE 
DIRECTOR
LUCY THERAPEUTICS, INC.
AMY 
 
RIPKA 
EXECUTIVE OFFICER, DIRECTOR
LUCY THERAPEUTICS, INC.
JOHN 
 
RIPPLE 
DIRECTOR
VIRDANTE PHARMACEUTICALS, INC.   |  EXONICS THERAPEUTICS, INC.   |  LUCY THERAPEUTICS, INC.   |  PRAESIDIA BIOTHERAPEUTICS, INC.
RACHEL 
 
SHA 
DIRECTOR
LUCY THERAPEUTICS, INC.   |  DROPLET BIOSCIENCES, INC.   |  AXOFT, INC.   |  VAXESS TECHNOLOGIES, INC.   |  TERRESTRIAL BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-05-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-15 
2023-12-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-15 
2022-01-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-22 
2020-07-22
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-28 
2019-07-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#